Drug Shortage Report for GANCICLOVIR FOR INJECTION
| Report ID | 107563 |
| Drug Identification Number | 02404761 |
| Brand name | GANCICLOVIR FOR INJECTION |
| Common or Proper name | Ganciclovir for Injection |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | GANCICLOVIR |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 500mg SD Vial 10mL |
| ATC code | J05AB |
| ATC description | DIRECT ACTING ANTIVIRALS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-02-10 |
| Estimated end date | 2020-07-17 |
| Actual end date | 2020-06-29 |
| Shortage status | Resolved |
| Updated date | 2020-08-06 |
| Company comments | Fresenius Kabi Canada Ltd. is pleased to advise that replenishment inventories of our Ganciclovir for Injection, 500 mg, 10 mL, SD Vials will be available at all distribution centres , Monday, June 29th, 2020. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v8 | 2020-08-06 | French | Compare |
| v7 | 2020-08-06 | English | Compare |
| v6 | 2020-06-08 | French | Compare |
| v5 | 2020-06-08 | English | Compare |
| v4 | 2020-04-20 | French | Compare |
| v3 | 2020-04-20 | English | Compare |
| v2 | 2020-03-02 | French | Compare |
| v1 | 2020-03-02 | English | Compare |
Showing 1 to 8 of 8